Multiple regulatory domains within the-100 region of the beta interferon (IFN-P) promoter control the inducible response of the IFN gene to virus infection. In this study, we demonstrate that the formation of NF-KB-specific complexes on the positive regulatory domain II (PRDII) precedes the onset of detectable IFN-I transcription in Sendai virus-infected cells. By using NF-KB subunit-specific antibodies, a temporal shift in the composition of NF-KB subunits in association with the PRDII domain is detected as a function of time after virus infection. Furthermore, a virus-induced degradation of IKBBa (MAD3) protein is observed between 2 and 8 h after infection; at later times, de novo synthesis of IKBa restores IKBC(to levels found in uninduced cells and correlates with the down regulation of IFN-0 transcription. In cotransfection experiments using various NF-KB subunit expression plasmids and two copies of PRDIIINF-KB linked to a chloramphenicol acetyltransferase reporter gene, we demonstrate that expression of p65, c-Rel, or p50 or combinations of p5O-p65 and p65-c-Rel differentially stimulated PRDII-dependent transcription. Coexpression of IK.Ba completely abrogated p65-, c-Rel-, or p65-p50-induced gene activity. When the entire IFN-4 promoter (-281 to +19) was used in coexpression studies, synergistic stimulation of IFN-f promoter activity was obtained when NF-KB subunits were coexpressed together with the IFN regulatory factor 1 (IRF-1) transcription factor. Overexpression of either IKB or the IRF-2 repressor was able to abrogate inducibility of the IFN-jI promoter. Thus, multiple regulatory events-including differential activation of DNA-binding NF-cB heterodimers, degradation of IKBa, synergistic interaction between IRF-1 and NF-KB, and decreased repression by IKB and IRF-2-are all required for the transcriptional activation of the IFN-, promoter.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.